Targeting the endocannabinoid system in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Targeting the endocannabinoid system in Alzheimer's disease.

Targeting the endocannabinoid system in Alzheimer's disease.

http://www.wikidata.org/entity/Q33930000

about

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.The influence of cannabinoids on generic traits of neurodegeneration.Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review.Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms Anandamide Effects in a Streptozotocin-Induced Alzheimer's Disease-Like Sporadic Dementia in Rats The Role of Cannabis within an Emerging Perspective on Schizophrenia

P2860

Q34642593-043C14A9-A0F7-40DD-A8EE-7052964B5055 Q37074288-249DE7D5-1EAC-4723-9C23-B999BA4B6FDB Q37446027-6612F0F5-8D06-4540-AE13-D7A9D2DE171A Q37633222-EBFEBCB6-C52C-4DA4-B289-94CE9878EAD3 Q38156518-16013874-71C8-4C8E-A8FA-526A5ADC6556 Q39031134-CDC32045-CC06-4008-B8D9-8F0750138A87 Q56975629-3F7C03B3-DF78-4050-B008-55AACA1B2183 Q58552816-3F3C5FE3-3BE1-477B-8C0C-DF1F545E3CD9 Q58794814-530A52F8-3150-49DD-97B9-64D13C7EEE4A

P2860

Targeting the endocannabinoid system in Alzheimer's disease.

http://www.wikidata.org/entity/Q33930000

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Targeting the endocannabinoid system in Alzheimer's disease.

@ast

Targeting the endocannabinoid system in Alzheimer's disease.

@en

type

label

Targeting the endocannabinoid system in Alzheimer's disease.

@ast

Targeting the endocannabinoid system in Alzheimer's disease.

@en

prefLabel

Targeting the endocannabinoid system in Alzheimer's disease.

@ast

Targeting the endocannabinoid system in Alzheimer's disease.

@en

P1433

Q33930000-CAF0979D-671C-4650-917E-1FCB25287B0E

P1476

Q33930000-AE47ED4D-2CDB-45AC-8FF1-5E7AC0A5D551

P2093

Q33930000-1243D09D-6BBE-474B-8A84-DFA06BC8287C

Q33930000-FEE473B1-B5FD-45A6-83B1-39EB672F721C

P2860

Q33930000-06D255E5-C4BB-4D44-B6FA-61CFE80657D5

Q33930000-0AAEE458-02CD-44F7-9013-B8619865EA4F

Q33930000-0EAA3371-BE06-4BAC-B5B0-2378036D2DB1

Q33930000-1178C8C0-483E-4EF1-838F-190DE40F87BC

Q33930000-12BF2875-8565-49BA-A61E-07BD6D2132C1

Q33930000-158F69F0-4C94-4781-B853-281068CD8425

Q33930000-17855BA1-5B48-43FD-BECC-4EC78D191734

Q33930000-184CE22F-D96E-4E28-886A-1074AE7B64C6

Q33930000-1AC18816-AFD1-48C8-A8A2-0B4AFA0C0105

Q33930000-1DE4A74B-8093-470C-8C94-AAEDDDA1A01D

P304

Q33930000-3553944F-51D2-4BCE-B02E-154EEC557733

P31

Q33930000-063DB336-6788-4BFB-A422-8AF4896B04BF

P356

Q33930000-6E6BFC46-ED0A-4A11-8171-4819A8190FBE

P433

Q33930000-07E36518-7B0C-4EA4-A322-0BA01331FCFC

P478

Q33930000-88C16294-7E8D-4197-80F9-51BBD9462D7E

P577

Q33930000-B5A6A91D-194D-4082-9B53-41C7ACB41914

P698

Q33930000-085C5340-1875-416A-A733-B659458CF69E

P921

Q33930000-03A84144-530D-48C6-910D-98957E5284E9

Q33930000-7494880D-02D3-4546-85F6-1EA9E5F2FD3A

P932

Q33930000-2BE3E578-76F3-48B0-A99D-EF4EB7C71F32

P356

P1433

Journal of Alzheimer's Disease

P1476

Targeting the endocannabinoid system in Alzheimer's disease

@en

P2093

Jeremy Koppel

http://www.w3.org/2001/XMLSchema#string

Peter Davies

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

Cannabinoid receptor localization in brain

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

Emerging roles for endocannabinoids in long-term synaptic plasticity

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

Cannabinoids control spasticity and tremor in a multiple sclerosis model

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

P304

495-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2008-15315

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18997302

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

endocannabinoid system

P932

2889705

http://www.w3.org/2001/XMLSchema#string